Scalper1 News
Shares of gene-sequencing company Illumina (ILMN) rose more than 8% in afternoon trading on the stock market today, near an all-time high, as analysts hiked their estimates following the firm’s Q3 earnings report, released late Monday. Illumina’s Q3 earnings handily beat estimates and led to a 2014 guidance increase, which in turn led analysts to hike their 2015 numbers and in some cases their price targets. ISI Group analyst Ross Muken raised his Scalper1 News
Scalper1 News